These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30032412)

  • 1. Radotinib-induced eruptive melanocytic nevi in patient with chronic myeloid leukemia: a case report and literature review.
    Park E; Jue MS
    Ann Hematol; 2019 Feb; 98(2):533-535. PubMed ID: 30032412
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of dysplastic nevus during radotinib therapy in patients with chronic myeloid leukemia.
    Woo YR; Kim JS; Kim DW; Park HJ
    Indian J Dermatol Venereol Leprol; 2017; 83(6):704-707. PubMed ID: 28891531
    [No Abstract]   [Full Text] [Related]  

  • 3. Eruptive Melanocytic Naevi Caused by Radotinib Therapy in Patients with Chronic Myeloid Leukaemia: 10 cases and a literature Review.
    Kim M; Yoon YH; Lee JH; Kim DW; Park HJ
    Acta Derm Venereol; 2017 Jan; 97(1):115-116. PubMed ID: 27276507
    [No Abstract]   [Full Text] [Related]  

  • 4. Widespread eruptive dermal and atypical melanocytic nevi in association with chronic myelocytic leukemia: case report and review of the literature.
    Richert S; Bloom EJ; Flynn K; Seraly MP
    J Am Acad Dermatol; 1996 Aug; 35(2 Pt 2):326-9. PubMed ID: 8698918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of a radotinib dosage regimen based on dose-response relationships for the treatment of newly diagnosed patients with chronic myeloid leukemia.
    Noh H; Jung SY; Kwak JY; Kim SH; Oh SJ; Zang DY; Lee S; Park HL; Jo DJ; Shin JS; Do YR; Kim DW; Lee JI
    Cancer Med; 2018 May; 7(5):1766-1773. PubMed ID: 29577681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eruptive nevi associated with medications (ENAMs).
    Perry BM; Nguyen A; Desmond BL; Blattner CM; Thomas RS; Young RJ
    J Am Acad Dermatol; 2016 Nov; 75(5):1045-1052. PubMed ID: 27241804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Squamous cell carcinoma in a chronic myelogenous leukemia patient treated with imatinib mesylate.
    Fujii M; Iwasaki T; Takahashi I; Kishiyama K; Honma M; Takahashi H; Ishida-Yamamoto A; Iizuka H
    J Dermatol; 2015 Mar; 42(3):338-9. PubMed ID: 25580575
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug-induced eruptive melanocytic nevi.
    Vena GA; Fargnoli MC; Cassano N; Argenziano G
    Expert Opin Drug Metab Toxicol; 2017 Mar; 13(3):293-300. PubMed ID: 27759434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eruptive melanocytic nevi induced by interferon for nodal metastatic melanoma: case report and review of the literature.
    Salopek TG; Mahmood MN
    J Cutan Med Surg; 2013; 17(6):410-3. PubMed ID: 24138978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase III Clinical Trial (RERISE study) Results of Efficacy and Safety of Radotinib Compared with Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia.
    Kwak JY; Kim SH; Oh SJ; Zang DY; Kim H; Kim JA; Do YR; Kim HJ; Park JS; Choi CW; Lee WS; Mun YC; Kong JH; Chung JS; Shin HJ; Kim DY; Park J; Jung CW; Bunworasate U; Comia NS; Jootar S; Reksodiputro AH; Caguioa PB; Lee SE; Kim DW
    Clin Cancer Res; 2017 Dec; 23(23):7180-7188. PubMed ID: 28939746
    [No Abstract]   [Full Text] [Related]  

  • 11. Eruptive melanocytic nevi with satellite lesions following insulin treatment in a girl with type 1 diabetes mellitus.
    Kim DH; Lee JS; Koo DW; Jung KE
    J Dermatol; 2015 May; 42(5):547-8. PubMed ID: 25766430
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of a dried blood spot sampling method towards therapeutic monitoring of radotinib in the treatment of chronic myeloid leukaemia.
    Lee J; Jung SY; Choi MY; Park JS; Park SK; Lim SA; Cho KH; Oh SY; Ha J; Kim DW; Lee J
    J Clin Pharm Ther; 2020 Oct; 45(5):1006-1013. PubMed ID: 32022312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multiple post-chemotherapy plantar nevi].
    Hueso L; Requena C; Serra-Guillén C; Alfaro A; Nagore E; Llombart B; Botella-Estrada R; Sanmartín O; Guillén C
    Actas Dermosifiliogr; 2006 Jun; 97(5):327-9. PubMed ID: 16956565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary cutaneous anaplastic large-cell lymphoma occurring in a case of chronic myeloid leukemia in remission.
    Charafeddine KM; Farchoukh LO; Khalifeh I
    J Cutan Pathol; 2012 Sep; 39(9):884-6. PubMed ID: 22775801
    [No Abstract]   [Full Text] [Related]  

  • 15. Multiple squamous cell carcinomas of the skin during long-term treatment with hydroxyurea.
    De Simone C; Guerriero C; Guidi B; Rotoli M; Venier A; Tartaglione R
    Eur J Dermatol; 1998 Mar; 8(2):114-5. PubMed ID: 9649662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Eruptive naevi associated with octreotide treatment].
    Michel JL
    Ann Dermatol Venereol; 2011 Oct; 138(10):677-80. PubMed ID: 21978505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eruptive multiple lentigo-maligna-like lesions in a patient undergoing chemotherapy with an oral 5-fluorouracil prodrug for metastasizing colorectal carcinoma: a lesson for the pathogenesis of malignant melanoma?
    Bogenrieder T; Weitzel C; Schölmerich J; Landthaler M; Stolz W
    Dermatology; 2002; 205(2):174-5. PubMed ID: 12218237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Darkening and eruptive nevi during treatment with erlotinib.
    Hemperly S; Ermolovich T; Lountzis NI; Sheikh HA; Purcell SM
    Cutis; 2019 Jul; 104(1):E19-E21. PubMed ID: 31487352
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of growth hormone therapy on melanocytic nevi in survivors of childhood neoplasia.
    Zvulunov A; Wyatt DT; Rabinowitz LG; Esterly NB
    Arch Dermatol; 1997 Jun; 133(6):795-6. PubMed ID: 9197843
    [No Abstract]   [Full Text] [Related]  

  • 20. Induction of eruptive benign melanocytic naevi by immune suppressive agents, including biologicals.
    Bovenschen HJ; Tjioe M; Vermaat H; de Hoop D; Witteman BM; Janssens RW; Stoof TJ; van de Kerkhof PC
    Br J Dermatol; 2006 May; 154(5):880-4. PubMed ID: 16634890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.